Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
SIGYSigyn Therapeutics, Inc.
| Figure | SIGYSigyn Therapeutics, Inc.FY2019 · Dec |
|---|---|
| Revenue | $143.32K |
| Revenue, yoy | +405.6% |
| Net income | $3.34M |
| Net income, yoy | +19.4% |
| Net margin | — |
| Free cash flow | $1.83M |
| FCF margin | — |
| EPS, diluted | $2.51 |
Add another company.
Annual · FY2014–FY2019 · USD
From SEC EDGARSame fiscal periods, as filed